Works by Laribi, Kamel

Results: 57
    1
    2

    Real‐life effectiveness of carfilzomib in patients with relapsed multiple myeloma receiving treatment in the context of early access: The CARMYN study.

    Published in:
    EJHaem, 2024, v. 5, n. 1, p. 55, doi. 10.1002/jha2.828
    By:
    • Laribi, Kamel;
    • Leleu, Xavier;
    • Texier, Nathalie;
    • Germain, Raphaël;
    • Touzeau, Cyrille;
    • Hammoud, Mohammad;
    • Payssot, Alexandre;
    • Schulmann, Samantha;
    • Le Calloch, Ronan;
    • Trebouet, Adrien;
    • Chaoui, Driss;
    • David, Selva;
    • Benbrahim, Omar;
    • Benramdane, Riad;
    • Charvet‐Rumpler, Anne;
    • Jadeau, Christelle;
    • Rouanet, Eglantine;
    • Decaux, Olivier;
    • Perrot, Aurore
    Publication type:
    Article
    3

    Real‐world clinical effectiveness and safety of CT‐P10 in patients with diffuse large B‐cell lymphoma: An observational study in Europe.

    Published in:
    EJHaem, 2023, v. 4, n. 1, p. 45, doi. 10.1002/jha2.593
    By:
    • Bishton, Mark J.;
    • Salles, Gilles;
    • Golfier, Camille;
    • Knauf, Wolfgang;
    • Bocchia, Monica;
    • Turner, Deborah;
    • Slama, Borhane;
    • Harchowal, Jatinder;
    • Marshall, Scott;
    • Bosi, Alberto;
    • Lleonart, Juan José Bargay;
    • Welslau, Manfred;
    • Kim, SooKyoung;
    • Lee, Young N.;
    • Zinzani, Pier L.;
    • Laribi, Kamel
    Publication type:
    Article
    4
    5

    Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-51264-2
    By:
    • Guièze, Romain;
    • Ysebaert, Loïc;
    • Roos-Weil, Damien;
    • Fornecker, Luc-Mathieu;
    • Ferrant, Emmanuelle;
    • Molina, Lysiane;
    • Aurran, Thérèse;
    • Clavert, Aline;
    • de Guibert, Sophie;
    • Michallet, Anne-Sophie;
    • Saad, Alain;
    • Drénou, Bernard;
    • Quittet, Philippe;
    • Hivert, Bénédicte;
    • Laribi, Kamel;
    • Gay, Julie;
    • Quinquenel, Anne;
    • Broseus, Julien;
    • Rouille, Valérie;
    • Schwartz, David
    Publication type:
    Article
    6
    7
    8

    Le syndrome de Shwachman-Diamond : à propos d'un cas.

    Published in:
    Annales de Biologie Clinique, 2018, v. 76, n. 4, p. 435, doi. 10.1684/abc.2018.1358
    By:
    • Kaabar, Mohamed;
    • Lemaire, Pierre;
    • Cussac, VincENt;
    • Besancon, Anne;
    • Martin-Coignard, Dominique;
    • FENneteau, Odile;
    • Laribi, Kamel;
    • Pineau-VincENt, FabiENne
    Publication type:
    Article
    9
    10
    11
    12

    Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 10, p. 1870, doi. 10.1002/ajh.27417
    By:
    • Garciaz, Sylvain;
    • Dumas, Pierre‐Yves;
    • Bertoli, Sarah;
    • Sallman, David A.;
    • Decroocq, Justine;
    • Belhabri, Amine;
    • Orvain, Corentin;
    • Aspas Requena, Gaspar;
    • Simand, Celestine;
    • Laribi, Kamel;
    • Carré, Martin;
    • Santagostino, Alberto;
    • Himberlin, Chantal;
    • Peterlin, Pierre;
    • Bonnet, Sarah;
    • Chan, Onyee;
    • Lancet, Jeffrey;
    • Komrokji, Rami;
    • Vergez, François;
    • Chapuis, Nicolas
    Publication type:
    Article
    13

    Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO).

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 9, p. E353, doi. 10.1002/ajh.26274
    By:
    • Lazarian, Grégory;
    • Munger, Michaël;
    • Quinquenel, Anne;
    • Dilhuydy, Marie‐Sarah;
    • Veronese, Lauren;
    • Luque Paz, Damien;
    • Guièze, Romain;
    • Ledoux‐Pilon, Albane;
    • Paillassa, Jérôme;
    • Merabet, Fatiha;
    • Vial, Jean‐Philippe;
    • Bidet, Audrey;
    • Waultier Rascalou, Agathe;
    • Broseus, Julien;
    • Roos‐Weil, Damien;
    • Lavaud, Anne;
    • Molina, Lysiane;
    • Laribi, Kamel;
    • Hivert, Bénédicte;
    • Friedrich, Chloé
    Publication type:
    Article
    14

    Characteristics of chronic lymphocytic leukemia patients achieving 5+ years of remission after FC-based first-line treatment: Retrospective observations from the FILO group.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 1, p. E24, doi. 10.1002/ajh.24951
    By:
    • Guillermin, Yann;
    • Herbaux, Charles;
    • Subtil, Fabien;
    • Aurran‐Schleinitz, Thérèse;
    • Cymbalista, Florence;
    • Letestu, Remi;
    • Leprêtre, Stéphane;
    • Vaudaux, Sandrine;
    • Laribi, Kamel;
    • Leblond, Véronique;
    • Defoi, Yasmina;
    • Benchikh, Raouf;
    • Salles, Gilles;
    • Godmer, Pascal;
    • Jardel, Henry;
    • Vallais, Fréderic;
    • Feugier, Pierre;
    • Orsini, Frédérique;
    • Pegourié, Brigitte;
    • Lévy, Vincent
    Publication type:
    Article
    15
    16

    Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy.

    Published in:
    2021
    By:
    • Wei, Andrew H.;
    • Panayiotidis, Panayiotis;
    • Montesinos, Pau;
    • Laribi, Kamel;
    • Ivanov, Vladimir;
    • Kim, Inho;
    • Novak, Jan;
    • Stevens, Don A.;
    • Fiedler, Walter;
    • Pagoni, Maria;
    • Bergeron, Julie;
    • Ting, Stephen B.;
    • Hou, Jing-Zhou;
    • Anagnostopoulos, Achilles;
    • McDonald, Andrew;
    • Murthy, Vidhya;
    • Yamauchi, Takahiro;
    • Wang, Jianxiang;
    • Chyla, Brenda;
    • Sun, Yan
    Publication type:
    Correction Notice
    17

    6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 10, p. 1, doi. 10.1038/s41408-021-00555-8
    By:
    • Wei, Andrew H.;
    • Panayiotidis, Panayiotis;
    • Montesinos, Pau;
    • Laribi, Kamel;
    • Ivanov, Vladimir;
    • Kim, Inho;
    • Novak, Jan;
    • Stevens, Don A.;
    • Fiedler, Walter;
    • Pagoni, Maria;
    • Bergeron, Julie;
    • Ting, Stephen B.;
    • Hou, Jing-Zhou;
    • Anagnostopoulos, Achilles;
    • McDonald, Andrew;
    • Murthy, Vidhya;
    • Yamauchi, Takahiro;
    • Wang, Jianxiang;
    • Chyla, Brenda;
    • Sun, Yan
    Publication type:
    Article
    18

    S210: AN OPEN‐LABEL, GLOBAL, PHASE (PH) 1B/2 STUDY ADDING NAVTEMADLIN (NVTM) TO RUXOLITINIB (RUX) IN PATIENTS (PTS) WITH PRIMARY OR SECONDARY MYELOFIBROSIS (MF) WHO HAVE A SUBOPTIMAL RESPONSE TO RUX.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000967752.72578.ff
    By:
    • Mascarenhas, John;
    • Jain, Tania;
    • Otoukesh, Salman;
    • Gerds, Aaron T.;
    • Lucchesi, Alessandro;
    • Romina Sosa, Iberia;
    • Laribi, Kamel;
    • Mishchenko, Elena;
    • Radinoff, Atanas;
    • Benevolo, Giulia;
    • Vannucchi, Alessandro M.;
    • Boyer, Francoise;
    • Quittet, Philippe;
    • Radsak, Markus;
    • Machet, Antoine;
    • Bose, Prithviraj;
    • Huang, Zhuying;
    • Qamoos, Hope;
    • Mcgreivy, Jesse;
    • Rothbaum, Wayne P.
    Publication type:
    Article
    19
    20

    Therapy‐related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy.

    Published in:
    HemaSphere, 2022, v. 6, n. 6, p. e716, doi. 10.1097/HS9.0000000000000716
    By:
    • Laribi, Kamel;
    • Baugier de Materre, Alix;
    • Ghez, David;
    • Dartigeas, Caroline;
    • Tomowiak, Cécile;
    • Mahé, Béatrice;
    • Micol, Jean‐Baptiste;
    • Merabet, Fatiha;
    • Leprêtre, Stéphane;
    • Herbaux, Charles;
    • Ysebaert, Loïc;
    • Le Calloch, Ronan;
    • Willems, Lise;
    • Voldoire, Maud;
    • Roos‐Weil, Damien;
    • Bravetti, Clotilde;
    • Touileb, Yamina;
    • Davi, Frédéric;
    • Nguyen‐Khac, Florence;
    • Maloum, Karim
    Publication type:
    Article
    21
    22

    Azacitidine and venetoclax with or without pevonedistat in patients with newly diagnosed acute myeloid leukemia.

    Published in:
    Leukemia & Lymphoma, 2025, v. 66, n. 3, p. 458, doi. 10.1080/10428194.2024.2431878
    By:
    • Short, Nicholas J.;
    • Wierzbowska, Agnieszka;
    • Cluzeau, Thomas;
    • Laribi, Kamel;
    • Recher, Christian;
    • Czyz, Jaroslaw;
    • Ochrem, Bogdan;
    • Ades, Lionel;
    • Gallego-Hernanz, Maria Pilar;
    • Heiblig, Mael;
    • Audisio, Ernesta;
    • Zarzycka, Ewa;
    • Li, Shuli;
    • Ferenc, Nicholas;
    • Yeh, Tammie;
    • Faller, Douglas V.;
    • Sedarati, Farhad;
    • Papayannidis, Cristina
    Publication type:
    Article
    23

    Lymphomas with kidney involvement: the French multicenter retrospective LyKID study.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 4, p. 887, doi. 10.1080/10428194.2019.1697811
    By:
    • Kohn, Milena;
    • Karras, Alexandre;
    • Zaidan, Mohamad;
    • Bénière, Charles;
    • de Fréminville, Jean-Baptiste;
    • Laribi, Kamel;
    • Perrin, Marie Claire;
    • Malphettes, Marion;
    • Le Calloch, Ronan;
    • Anglaret, Bruno;
    • Martiniuc, Juliana;
    • Bailly, Sarah;
    • Chevret, Sylvie;
    • Molina, Thierry;
    • Thervet, Eric;
    • Thieblemont, Catherine
    Publication type:
    Article
    24
    25

    Gastrointestinal Behcet's-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 7, p. 1782, doi. 10.1080/10428194.2018.1542152
    By:
    • Wesner, Nadege;
    • Drevon, Louis;
    • Guedon, Alexis;
    • Fraison, Jean Baptiste;
    • Terrier, Benjamin;
    • Trad, Salim;
    • Kahn, Jean Emmanuel;
    • Aouba, Achille;
    • Gillard, Jerome;
    • Ponsoye, Matthieu;
    • Hanslik, Thomas;
    • Gourguechon, Clement;
    • Liozon, Eric;
    • Laribi, Kamel;
    • Rossignol, Julien;
    • Hermine, Olivier;
    • Seksik, Philippe;
    • Adès, Lionel;
    • Carrat, Fabrice;
    • Fenaux, Pierre
    Publication type:
    Article
    26
    27

    Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia.

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 2, p. 328, doi. 10.3109/10428194.2015.1063139
    By:
    • Dartigeas, Caroline;
    • Van Den Neste, Eric;
    • Berthou, Christian;
    • Maisonneuve, Hervé;
    • Leprêtre, Stéphane;
    • Dilhuydy, Marie-Sarah;
    • Béné, Marie-Christine;
    • Nguyen-Khac, Florence;
    • Letestu, Rémi;
    • Cymbalista, Florence;
    • De Guibert, Sophie;
    • Aurran, Thérèse;
    • Laribi, Kamel;
    • Vilque, Jean-Pierre;
    • Tournilhac, Olivier;
    • Delmer, Alain;
    • Feugier, Pierre;
    • Cazin, Bruno;
    • Michallet, Anne-Sophie;
    • Lévy, Vincent
    Publication type:
    Article
    28

    Efficacy and safety of pegylated-interferon α-2a in myelofibrosis: a study by the FIM and GEM French cooperative groups.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 6, p. 783, doi. 10.1111/bjh.12459
    By:
    • Ianotto, Jean‐Christophe;
    • Boyer‐Perrard, Françoise;
    • Gyan, Emmanuel;
    • Laribi, Kamel;
    • Cony‐Makhoul, Pascale;
    • Demory, Jean‐Loup;
    • Renzis, Benoit;
    • Dosquet, Christine;
    • Rey, Jerome;
    • Roy, Lydia;
    • Dupriez, Brigitte;
    • Knoops, Laurent;
    • Legros, Laurence;
    • Malou, Mohamed;
    • Hutin, Pascal;
    • Ranta, Dana;
    • Schoenwald, Michele;
    • Andreoli, Annalisa;
    • Abgrall, Jean‐François;
    • Kiladjian, Jean‐Jacques
    Publication type:
    Article
    29

    High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B-cell lymphoma in first relapse: results of the R- NIMP GOELAMS study.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 2, p. 240, doi. 10.1111/bjh.12379
    By:
    • Gyan, Emmanuel;
    • Damotte, Diane;
    • Courby, Stéphane;
    • Sénécal, Delphine;
    • Quittet, Philippe;
    • Schmidt‐Tanguy, Aline;
    • Banos, Anne;
    • Gouill, Steven;
    • Lamy, Thierry;
    • Fontan, Jean;
    • Maisonneuve, Hervé;
    • Alexis, Magda;
    • Dreyfus, Francois;
    • Tournilhac, Olivier;
    • Laribi, Kamel;
    • Solal‐Céligny, Philippe;
    • Arakelyan, Nina;
    • Cartron, Guillaume;
    • Gressin, Remy
    Publication type:
    Article
    30

    Cardiac failure in patients treated with azacitidine, a pyrimidine analogue: Case reports and disproportionality analyses in Vigibase.

    Published in:
    British Journal of Clinical Pharmacology, 2020, v. 86, n. 5, p. 991, doi. 10.1111/bcp.14211
    By:
    • Perino, Justine;
    • Mottal, Nathan;
    • Bohbot, Yohann;
    • Servant, Vincent;
    • Berroneau, Aude;
    • Poustis, Pierre;
    • Fenaux, Pierre;
    • Laribi, Kamel;
    • Charbonnier, Aude;
    • Bilion, Emilien;
    • Calmettes, Claire;
    • Bégaud, Bernard;
    • Pigneux, Arnaud;
    • Milpied, Noël;
    • Miremont‐Salamé, Ghada;
    • Théophile, Hélène;
    • Dimicoli‐Salazar, Sophie
    Publication type:
    Article
    31

    Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 976, doi. 10.1002/hon.3044
    By:
    • Younan, Nadia;
    • Soussain, Carole;
    • Choquet, Sylvain;
    • Cassoux, Nathalie;
    • Touitou, Valérie;
    • Schmitt, Anna;
    • Chinot, Olivier;
    • Oberic, Lucie;
    • Damaj, Gandhi;
    • Houot, Roch;
    • Ghesquières, Hervé;
    • Laribi, Kamel;
    • Ahle, Guido;
    • Taillandier, Luc;
    • Paillassa, Jérôme;
    • Gyan, Emmanuel;
    • Jardin, Fabrice;
    • Delwail, Vincent;
    • Marolleau, Jean‐Pierre;
    • Tempescul, Adrian
    Publication type:
    Article
    32
    33
    34

    Influence of FCGR3A-158V/F Genotype and Baseline CD20 Antigen Count on Target-Mediated Elimination of Rituximab in Patients with Chronic Lymphocytic Leukemia: A Study of FILO Group.

    Published in:
    2017
    By:
    • Tout, Mira;
    • Gagez, Anne-Laure;
    • Leprêtre, Stéphane;
    • Gouilleux-Gruart, Valérie;
    • Azzopardi, Nicolas;
    • Delmer, Alain;
    • Mercier, Mélanie;
    • Ysebaert, Loïc;
    • Laribi, Kamel;
    • Gonzalez, Hugo;
    • Paintaud, Gilles;
    • Cartron, Guillaume;
    • Ternant, David;
    • Leprêtre, Stéphane;
    • Gouilleux-Gruart, Valérie;
    • Mercier, Mélanie;
    • Ysebaert, Loïc
    Publication type:
    journal article
    35
    36
    37

    Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 4, p. 987, doi. 10.1007/s00277-021-04419-w
    By:
    • Bouclet, Florian;
    • Calleja, Anne;
    • Dilhuydy, Marie-Sarah;
    • Véronèse, Lauren;
    • Pereira, Bruno;
    • Amorim, Sandy;
    • Cymbalista, Florence;
    • Herbaux, Charles;
    • de Guibert, Sophie;
    • Roos-Weil, Damien;
    • Hivert, Bénédicte;
    • Aurran, Thérèse;
    • Dupuis, Jehan;
    • Blouet, Anaise;
    • Tchernonog, Emmanuelle;
    • Laribi, Kamel;
    • Dmytruck, Nataliya;
    • Morel, Pierre;
    • Michallet, Anne-Sophie;
    • Dartigeas, Caroline
    Publication type:
    Article
    38

    Impact of front line relative dose intensity for methotrexate and comorbidities in immunocompetent elderly patients with primary central nervous system lymphoma.

    Published in:
    Annals of Hematology, 2018, v. 97, n. 12, p. 2391, doi. 10.1007/s00277-018-3468-5
    By:
    • Orvain, Corentin;
    • Mercier, Mélanie;
    • Sutra Del Galy, Aurélien;
    • Clavert, Aline;
    • Tanguy-Schmidt, Aline;
    • Hunault-Berger, Mathilde;
    • Moles-Moreau, Marie-Pierre;
    • Farhi, Jonathan;
    • Laribi, Kamel;
    • Hamel, Jean-François;
    • Rousselet, Marie-Christine
    Publication type:
    Article
    39
    40
    41

    Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 6, p. 7175, doi. 10.1002/cam4.5459
    By:
    • Laloi, Louise;
    • Billotey, Natacha Chaumard;
    • Dumas, Pierre‐Yves;
    • Paul, Franciane;
    • Villate, Alban;
    • Simand, Célestine;
    • Fornecker, Luc;
    • Puisset, Florent;
    • Bertoli, Sarah;
    • Simonet, Marion Boissard;
    • Laribi, Kamel;
    • Houyou, Dyhia;
    • Santagostino, Alberto;
    • Michel, Claire;
    • Guepin, Gabrielle Roth;
    • Guerineau, Elodie;
    • Tabrizi, Reza;
    • Hunault, Mathilde;
    • Giltat, Aurélien;
    • Kaphan, Eléonore
    Publication type:
    Article
    42
    43

    Long‐term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO).

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 6, p. 2233, doi. 10.1111/bjh.19409
    By:
    • Laribi, Kamel;
    • Poulain, Stéphanie;
    • Willems, Lise;
    • Merabet, Fatiha;
    • Herbaux, Charles;
    • Roos‐Weil, Damien;
    • Laribi de Materre, Inès;
    • Roussel, Xavier;
    • Nudel, Morgane;
    • Tricot, Sabine;
    • Dupuis, Jehan;
    • Le Calloch, Ronan;
    • Bareau, Benoit;
    • Leblond, Véronique
    Publication type:
    Article
    44

    A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher‐Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 3, p. 535, doi. 10.1111/bjh.18193
    By:
    • Adès, Lionel;
    • Duployez, Nicolas;
    • Guerci‐Bresler, Agnes;
    • Laribi, Kamel;
    • Peterlin, Pierre;
    • Vey, Norbert;
    • Thepot, Sylvain;
    • Wickenhauser, Stefan;
    • Zerazhi, Hacene;
    • Stamatoullas, Aspassia;
    • Wattel, Eric;
    • Recher, Christian;
    • Toma, Andrea;
    • Dimicoli‐Salazar, Sophie;
    • Braun, Thorsten;
    • Beyne‐Rauzy, Odile;
    • Marolleau, Jean‐Pierre;
    • Cheze, Stéphane;
    • Park, Sophie;
    • Cluzeau, Thomas
    Publication type:
    Article
    45
    46

    Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real‐life study.

    Published in:
    British Journal of Haematology, 2021, v. 194, n. 2, p. 336, doi. 10.1111/bjh.17539
    By:
    • Comont, Thibault;
    • Meunier, Mathieu;
    • Cherait, Amina;
    • Santana, Clemence;
    • Cluzeau, Thomas;
    • Slama, Bohrane;
    • Laribi, Kamel;
    • Giraud, Jean‐Thomas;
    • Dimicoli, Sophie;
    • Berceanu, Ana;
    • Le Clech, Lenaïg;
    • Cony‐Makhoul, Pascale;
    • Gruson, Berangere;
    • Torregrosa, Jose;
    • Sanhes, Laurence;
    • Jachiet, Vincent;
    • Azerad, Marie‐Agnes;
    • Al Jijakli, Ahmad;
    • Gyan, Emmanuel;
    • Gaudin, Clement
    Publication type:
    Article
    47

    Characterisation of a new clinical presentation of chronic lymphocytic leukaemia: symptomatic bronchial involvement, a study from the FILO group.

    Published in:
    British Journal of Haematology, 2019, v. 186, n. 5, p. e126, doi. 10.1111/bjh.15966
    By:
    • Nudel, Morgane;
    • Baran‐Marszak, Fanny;
    • Bossard, Jean‐Baptiste;
    • Dubois, Romain;
    • Dapvril, Héloïse;
    • Dupuis, Jehan;
    • Laribi, Kamel;
    • Bay, Jacques‐Olivier;
    • Tomowiak, Cécile;
    • Dreyfus, Brigitte;
    • Lepretre, Stéphane;
    • Demarquette, Hélène;
    • Wallyn, Frédéric;
    • Wemeau, Lidwine;
    • Wemeau, Mathieu;
    • Poulain, Stéphanie;
    • Morschhauser, Franck;
    • Cymbalista, Florence;
    • Herbaux, Charles
    Publication type:
    Article
    48

    Bendamustine plus rituximab in newly‐diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).

    Published in:
    British Journal of Haematology, 2019, v. 186, n. 1, p. 146, doi. 10.1111/bjh.15718
    By:
    • Laribi, Kamel;
    • Poulain, Stéphanie;
    • Willems, Lise;
    • Merabet, Fatiha;
    • Le Calloch, Ronan;
    • Eveillard, Jean R.;
    • Herbaux, Charles;
    • Roos‐Weil, Damien;
    • Chaoui, Driss;
    • Roussel, Xavier;
    • Tricot, Sabine;
    • Dupuis, Jehan;
    • Dartigeas, Caroline;
    • Bareau, Benoit;
    • Bene, Marie C.;
    • Baugier de Materre, Alix;
    • Leblond, Véronique
    Publication type:
    Article
    49

    Bendamustine and rituximab in elderly patients with low‐tumour burden follicular lymphoma. Results of the LYSA phase II BRIEF study.

    Published in:
    British Journal of Haematology, 2018, v. 183, n. 1, p. 76, doi. 10.1111/bjh.15513
    By:
    • Gyan, Emmanuel;
    • Sonet, Anne;
    • Brice, Pauline;
    • Anglaret, Bruno;
    • Laribi, Kamel;
    • Fruchart, Christophe;
    • Tilly, Hervé;
    • Araujo, Carla;
    • Soubeyran, Pierre;
    • Gonzalez, Hugo;
    • Morineau, Nadine;
    • Nicolas‐Virelizier, Emmanuelle;
    • Ghesquières, Hervé;
    • Salles, Bruno;
    • Bouabdallah, Réda;
    • Orfeuvre, Hubert;
    • Fahri, Jonathan;
    • Couturier, Olivier;
    • Xerri, Luc;
    • Feugier, Pierre
    Publication type:
    Article
    50